6533b7dbfe1ef96bd126feb6
RESEARCH PRODUCT
ASCO-Update 2015 – Neuigkeiten vom 51. Meeting der American Society of Clinical Oncology/ASCO 2015
Thomas SeufferleinAnke Reinacher-schickSylvie LorenzenMarkus MoehlerMatthias M. WeberChristian FottnerDirk ArnoldJonas LeichsenringArndt Vogelsubject
Clinical Oncologymedicine.medical_specialtyPathologybusiness.industryColorectal cancerGastroenterologyContext (language use)PerioperativeEvidence-based medicineEsophageal cancermedicine.diseaseClinical trialPancreatic cancerMedicinebusinessIntensive care medicinedescription
The field of gastrointestinal oncology is rapidly developing, on the one hand through the identification of novel molecular targets and therapeutic principles, on the other hand through the establishment and improvement of multidisciplinary treatment strategies. The following manuscript summarizes the most important trial results of the ASCO Meeting 2015 for gastrointestinal cancers. Besides trials on perioperative treatment of esophageal-, pancreatic- and colon cancer, we will present impressive data on new therapeutic strategies such as immunotherapy in gastric-, liver and microsatellite instable colorectal cancer. The trials will be put into context by the authors.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2016-02-08 | Zeitschrift für Gastroenterologie |